Search results
Diabetic ketoacidosis (DKA) is a frequent and potentially life-threatening complication of type 1 diabetes. Though preventable and despite advances in monitoring technologies, insulin therapeutics and insulin delivery systems, the rates of both community and hospital acquired DKA remain largely unchanged. Although mortality today is relatively
6 sie 2021 · Every hospital will have a DKA protocol, which can generally be followed. However, it's still useful to understand the broad strokes of how insulin is utilized in DKA, as described below. (#1) insulin infusion: getting started. Unless the patient is hypokalemic (K <3.3 mM), insulin should be started immediately.
22 maj 2020 · MONTEFIORE SUBCUTANEOUS INSULIN DKA PROTOCOL. This is a subcutaneous (SubQ) insulin protocol that replaces insulin drip needs for mild to moderate DKA. Procedures are adapted for COVID-related considerations of minimizing risk to staff while optimizing patient safety and health.
DIABETIC KETOACIDOSIS – INITIAL MANAGEMENT GUIDE. DIAGNOSIS OF DKA BLOOD GLUCOSE(BG) > 11*- (glucose may be normal in a known diabetic) + ACIDOSIS - pH <7.3 or HCO3-<15mmol/l + KETONAEMIA – Bld Ketones> 3mmol/l.
This document presents a subcutaneous insulin protocol for treating mild to moderate diabetic ketoacidosis (DKA) developed by Montefiore hospital. The protocol outlines criteria for eligibility including blood pH and bicarbonate levels.
Prevent hypoglycemia. Determine inciting condition for the DKA. Correct hyperglycemia (secondary goal) When DKA resolved: begin appropriate SQ insulin before stopping Insulin drip. Frequent Vital signs. CALCULATE: Free Water Deficit. Basic metabolic panel, Serum phosphate level, hepatic enzymes, A1C. beta-HCG.
intravenous insulin, cbg and ketones monitoring record sheet Guide: Only use for patients on intravenous insulin regimen (use different chart for patients on subcutaneous insulin)
